Dr. Fosnaugh has more than 25 years of experience in biotech research and development including small molecule, RNA therapeutics, and delivery formulation programs. As Director of Program Management at Aminex Therapeutics, she coordinated late preclinical IND-enabling development and Phase 1 clinical trial initiation. Dr. Fosnaugh has held positions of increasing responsibility at Youtell Biochemical, Marina Therapeutics, Sirna Therapeutics, and Ligand Pharmaceuticals. She received her BS in Microbiology from the University of Illinois and her PhD in Microbiology at Cornell University, followed by postdoctoral research in developmental biology at the University of California, San Diego. Dr. Fosnaugh also completed Certification in Biomedical Regulatory Affairs at the University of Washington.